TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
147.20
+2.80 (1.94%)
At close: Jul 19, 2024, 4:00 PM
146.80
-0.40 (-0.27%)
Pre-market: Jul 22, 2024, 7:42 AM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.85 billion as of July 22, 2024. Its market cap has increased by 82.36% in one year.
Market Cap
4.85B
Enterprise Value
5.01B
1-Year Change
82.36%
Ranking
Category
Stock Price
$147.20
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $430.30M to $4.85B, an increase of 1,026.74%. That is a compound annual growth rate of 59.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.85B | 88.15% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.38% |
| Dec 31, 2021 | 532.00M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | 402.30M | -6.51% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 5.10B |
| Merit Medical Systems | 4.97B |
| Select Medical Holdings | 4.95B |
| PACS Group | 4.92B |
| BridgeBio Pharma | 4.90B |
| CRISPR Therapeutics AG | 4.63B |
| Apellis Pharmaceuticals | 4.61B |
| RadNet | 4.58B |